Abbas Haghparast Selected Research

Formaldehyde (Formol)

1/2022	Orexin receptors in the CA1 region of hippocampus modulate the stress-induced antinociceptive responses in an animal model of persistent inflammatory pain.
1/2022	Blocking the dopaminergic receptors in the hippocampal dentate gyrus reduced the stress-induced analgesia in persistent inflammatory pain in the rat.
1/2021	Orexin-2 receptor antagonism in the cornu ammonis 1 region of hippocampus prevented the antinociceptive responses induced by chemical stimulation of the lateral hypothalamus in the animal model of persistent pain.
1/2021	The role of dentate gyrus dopaminergic receptors in the lateral hypothalamic-induced antinociception during persistent inflammatory pain in male rats.
1/2021	Dopaminergic receptors in the ventral tegmental area modulated the lateral hypothalamic stimulation-induced antinociception in an animal model of tonic pain.
12/2020	Role of orexin receptors within the dentate gyrus in antinociception induced by chemical stimulation of the lateral hypothalamus in an animal model of inflammatory pain.
4/2020	Involvement of Orexinergic System Within the Nucleus Accumbens in Pain Modulatory Role of the Lateral Hypothalamus in Orofacial Pain Model.
1/2020	Modulatory role of hippocampal dopamine receptors in antinociceptive responses induced by chemical stimulation of the lateral hypothalamus in an animal model of persistent inflammatory pain.
1/2020	The contribution of orexin receptors within the ventral tegmental area to modulation of antinociception induced by chemical stimulation of the lateral hypothalamus in the animal model of orofacial pain in the rats.
5/2019	Spinal Orexin-2 Receptors are Involved in Modulation of the Lateral Hypothalamic Stimulation-Induced Analgesia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abbas Haghparast Research Topics

Disease

40	Pain (Aches) 05/2022 - 07/2006
13	Substance-Related Disorders (Drug Abuse) 03/2022 - 06/2014
13	Acute Pain 01/2022 - 12/2011
8	Morphine Dependence 03/2022 - 01/2008
6	Facial Pain (Myofacial Pain) 04/2020 - 12/2013
5	Chronic Pain 01/2022 - 08/2009
5	Memory Disorders (Memory Loss) 01/2019 - 08/2010
4	Neuralgia (Stump Neuralgia) 09/2021 - 10/2012
4	Hyperalgesia 09/2021 - 10/2012
4	Cognitive Dysfunction 01/2020 - 08/2010
4	Neoplasms (Cancer) 12/2019 - 12/2016
4	Mental Disorders (Mental Disorder) 01/2018 - 05/2014
3	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 01/2014
2	Apnea 11/2021 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 08/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2018 - 08/2015
2	Stroke (Strokes) 08/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 08/2017 - 12/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Dementia (Dementias) 01/2019
1	Coma (Comas) 10/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Poisoning 01/2018
1	Ischemic Stroke 01/2017

Drug/Important Bio-Agent (IBA)

26	Formaldehyde (Formol)FDA Link 01/2022 - 07/2006
18	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 07/2006
12	Orexin ReceptorsIBA 01/2022 - 12/2012
12	OrexinsIBA 01/2020 - 12/2012
10	Carbachol (Carbastat)FDA Link 01/2021 - 04/2013
9	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 12/2013
8	Opioid Analgesics (Opioids)IBA 01/2022 - 10/2007
7	Naloxone (Narcan)FDA LinkGeneric 01/2022 - 08/2008
6	Pharmaceutical PreparationsIBA 01/2020 - 05/2014
5	CannabidiolIBA 01/2022 - 01/2020
5	Analgesics (Analgesic Drugs)IBA 01/2021 - 10/2011
5	CannabinoidsIBA 01/2021 - 10/2011
4	Neuroprotective AgentsIBA 01/2020 - 08/2010
4	Minocycline (Cyclops)FDA LinkGeneric 12/2019 - 10/2012
3	Methamphetamine (Desoxyn)FDA LinkGeneric 03/2022 - 01/2014
3	1- (3,4- dihydro- 6,7- dimethoxy- 2(1H)- isoquinolinyl)- 3,3- dimethyl- 2- ((4- pyridinylmethyl)amino)- 1- butanoneIBA 01/2021 - 01/2016
3	SCH 23390IBA 12/2019 - 12/2013
3	PolyphenolsIBA 12/2016 - 08/2010
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2022
2	Methadone (Dolophine)FDA LinkGeneric 11/2021 - 01/2018
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2021 - 12/2019
2	Sulpiride (neogama)IBA 12/2019 - 08/2012
2	Insulin (Novolin)FDA Link 01/2019 - 05/2013
2	Gallic AcidIBA 10/2018 - 08/2015
2	Cholinergic ReceptorsIBA 06/2018 - 02/2015
2	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 09/2014 - 12/2013
2	QuinpiroleIBA 09/2014 - 12/2013
2	N-Methylaspartate (NMDA)IBA 12/2011 - 02/2008
2	Cannabinoid Receptor AgonistsIBA 12/2011 - 10/2011
2	CurcuminIBA 10/2010 - 08/2010
2	HomocysteineIBA 10/2010 - 08/2010
1	Capsaicin (Zostrix)FDA Link 05/2022
1	EndocannabinoidsIBA 03/2022
1	SolutionsIBA 01/2022
1	Nicotine FDA Link 01/2022
1	Orexin Receptor AntagonistsIBA 11/2021
1	Therapeutic UsesIBA 10/2021
1	MuscimolIBA 09/2021
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021
1	Central Nervous System StimulantsIBA 01/2021
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Dopamine AntagonistsIBA 01/2020
1	MethyltransferasesIBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Opiate AlkaloidsIBA 12/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Scopolamine (Hyoscine)FDA Link 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Malondialdehyde (Propanedial)IBA 10/2018
1	Interleukin-6 (Interleukin 6)IBA 10/2018
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2018
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 06/2018
1	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 06/2018
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2018
1	metabotropic glutamate receptor 2IBA 01/2018
1	NeuropeptidesIBA 12/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	ferric oxide (iron oxide)IBA 01/2017
1	Dextrans (Dextran)FDA Link 01/2017

Therapy/Procedure

11	Analgesia 01/2022 - 07/2006
3	Radiotherapy 10/2019 - 12/2016
2	Resuscitation 11/2021 - 01/2018
2	Therapeutics 01/2020 - 01/2020
1	Deep Brain Stimulation 01/2022
1	Withholding Treatment 01/2020
1	Drug Substitution 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Mechanical Ventilators (Ventilator) 01/2018
1	Bibliotherapy 09/2017
1	Endurance Training 01/2017